Treatment of asthma in patients 6yrs old not adequately controlled on a long-term asthma control medication [eg, inhaled corticosteroid (ICS)] or whose disease warrants initiation of both an ICS and LABA. Maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema
Manufacturer | Astrazeneca UK Limited |
---|---|
Dosage | COPD 2 puffs (160 mcg/4.5 mcg per actuation) twice daily 2 puffs (160 mcg/4.5 mcg per actuation) twice daily Asthma 2 puffs inhaled twice daily 2 puffs every 4 hours, as needed |
Dosage Form | spray |
Size | 120 dose |
Active Ingredients | budesonide and formoterol fumarate dihydrate |
Write Your Own Review